HKU Scholars Hub: Browsing DSpace

Browsing by Author Chang, TT

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 16 to 26 of 26 < previous

	Title	Author(s)	Issue Date	Views
	Long-term entecavir therapy results in reversal of fibrosis/cirrhosis and continued histologic improvement in patients with HBeAg(+) and (-) chronic hepatitis B: results from studies ETV-022, -027 and -901 Proceeding/Conference:Hepatology	Liaw, YF Chang, TT Wu, SS Schiff, ER Han, KH Lai, CL Safadi, R Lee, SS Halota, W Goodman, ZD Zhang, H Hindes, R Iloeje, U Beebe, S Kreter, B	2008	160
	Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B Journal:Hepatology	Chang, TT Liaw, YF Wu, SS Schiff, E Han, KH Lai, CL Safadi, R Lee, SS Halota, W Goodman, Z Chi, YC Zhang, H Hindes, R Iloeje, U Beebe, S Kreter, B	2010	180
	Long-term entecavir treatment for up to 5 years in Asians with HBEAG-positive nucleos(T)ide naïve chronic hepatitis B: results from ETV-022 and -901 Proceeding/Conference:Hepatology	Pan, C Tong, MJ Kowdley, KV Hu, KQ Chang, TT Lai, CL Yoon, SK Lee, SS Cohen, DS Tang, H Tsai, N	2010	63
	Long-Term Histologic Improvement with Entecavir (ETV) Therapy in Patients with Chronic Hepatitis B (CHB) from Japanese and Worldwide Development Programs Proceeding/Conference:Gastroenterology	Liaw, YF Chang, TT Wu, SS Schiff, ER Kan, KH Lai, CL Safadi, R Lee, SS Halota, W Goodman, ZD Zhang, H Iloeje, UH Beebe, S Kreter, B Ishikawa, H Katano, Y Takaguchi, K Omata, M	2009	14
	Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B Journal:Journal of Viral Hepatitis	Gish, RG Chang, TT Lai, CL De Man, R Gadano, A Poordad, F Yang, J BrettSmith, H Tamez, R	2010	103
	Loss of HBsAg in nucleoside-naive HBeAg(+) chronic hepatitis B patients following treatment with entecavir or lamivudine: evaluation of HBV genotypes Proceeding/Conference:Hepatology	Gish, RG Chang, TT Lai, CL De Man, RA Poordad, F Xu, D Brett-Smith, H Harris, M Iloeje, U Tang, H	2009
	A one-year trial of lamivudine for chronic hepatitis B Journal:New England Journal of Medicine	Lai, CL Chien, RN Leung, NWY Chang, TT Guan, R Tai, DI Ng, KY Wu, PC Dent, JC Barber, J Stephenson, SL Gray, DF	1998	169
	Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive, nucleoside-naive patients treated with entecavir Journal:Antiviral Therapy	Gish, RG Chang, TT Lai, CL de Man, RA Gadano, A Llamoso, C Tang, H	2013
	Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy Journal:Journal of Hepatology	Shouval, D Lai, CL Chang, TT Cheinquer, H Martin, P Carosi, G Han, S Kaymakoglu, S Tamez, R Yang, J Tenney, D BrettSmith, H	2009	183
	Tenofovir alafenamide (TAF) compared with Tenofovir Dispoproxil Fumarate (TDF) in patients with chronic HBV: week 96 efficacy and safety results in Chinese patients enrolled in 2 overseas phase 3 studies Proceeding/Conference:Chinese Infectious Disease and Hepatology Conference	Seto, WKW Fung, S Hou, J Pan, C Chuang, WL Chang, TT Hui, AJ Chen, CY Ma, X Tam, E Tsang, TY Yang, J Flaherty, JF Gaggar, A Mo, S Tong, M Kao, JH Chan, HL	2017
	Three years of entecavir (etv) re-treatment of HBeAg(-) etv patients who previously discontinued ETV treatment: results from study ETV-901 Proceeding/Conference:Hepatology	Shouval, D Lai, CL Chang, TT Gadano, A Wu, SS Halota, W Sievert, W Tsai, NCSC Zhang, H Iloeje, U	2008	172

Showing results 16 to 26 of 26 < previous